Back to Article List


Feb 03, 2020

The authorization of nicotinamide riboside chloride as a permitted source of Niacin in food supplements has been officially published in the EU official Journal and will enter into force next month, 2 February. The authorization has been awarded with data protection for the studies submitted within the novel food application. The data protection, which provides an exclusive right of commercialization, remains to the advantage of the US company ChromaDex Inc. until 20 February 2025. The conditions of use further specify that the use of nicotinamide riboside chloride should be limited to 300 mg/day for the general adult population, and to 230 mg/day for pregnant and lactating women.

Commission Implementing Regulation (EU) 2020/16 of 10 January 2020 authorising the placing on the market of nicotinamide riboside chloride as a novel food under Regulation (EU) 2015/2283 - link

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox